Previous Page  12 / 26 Next Page
Information
Show Menu
Previous Page 12 / 26 Next Page
Page Background

Immunology 2018

J u l y 0 5 - 0 7 , 2 0 1 8

V i e n n a , A u s t r i a

Page 43

Journal of Clinical Immunology and Allergy

ISSN 2471-304X

1 5

t h

I n t e r n a t i o n a l C o n f e r e n c e o n

Immunology

T

he overall objectives of our studies are to interrogate the roles of pregnancy-

associated glycosphingolipids (GSLs) in immune tolerance of pregnancy,

and exploit their potential immune modulatory activities. Although it was

demonstrated that one of the most prevalent tumor associated GSLs (Globo H

ceramide) acts as an immune checkpoint to suppress T and B lymphocytes, and

as an angiogenic factor to promote tumor growth in tumor microenvironment,

very little is known about the role of this and other GSLs in pregnancy. An

analogy to the immune suppressive milieu of the host microenvironment in

tumor tissues is the immune tolerance of pregnancy. A deeper understanding

of the events and the key regulators involved in the establishment of a healthy

embryo implantation remains a goal only incompletely realized. We expect

that GSLs mediated transfer from human microvilli, trophoblasts, or stromal

mesenchymal stem cells from either maternal chorio-decidua or fetal origin,

could be incorporated into immune cells and that certain GSLs may facilitate

immune tolerance, leading to successful implantation of embryo. Specifically,

we employ the new technology platforms, state of the art mass spec. facility,

as well as expertise in reproductive medicine and tumor immunology, to

explore an innovative concept concerning the embryo/endometrium crosstalk.

In addition, similar mechanistic investigation of the immune checkpoint and

angiogenesis activities will be carried out for uterine tissues and compared.

Through such endeavours, our studies will likely provide a roadmap for

heretofore un-chartered territory of research regarding the involvement of GSLs

in early embryogenesis and the key regulators involved in the establishment of

a healthy pregnancy.

Biography

John Yu is distinguished Chair Professor/Director at Institute

of Stem Cell/Translational Cancer Research, CGMH. He is also

distinguished Visiting Research Fellow at Institute of Cellular

and Organismic Biology, Academia Sinica, and was the Director

for the same Institute (2002-2009). He is the founding President

for Taiwan Society for Stem Cell Research. He was elected to

serve inmany ISSCR Committees USA, the Steering Committee

of Asia-Pacific Stem Cell Network, and advisor for Stem Cell

Biology, Kumamoto Univ. He was Director of Exp. Hematology

(1998-2002) at Scripps Research Institute, USA. He received

an established Investigatorship Award from American Heart

Assoc. and many other awards.

johnyu@gate.sinica.edu.tw

The role of glycosphingolipids in immune tolerance of pregnancy

John Yu

1

Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital, Taiwan

2

Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan

John Yu, Insights Allergy Asthma Bronchitis 2018, Volume: 4

DOI: 10.21767/2471-304X-C1-002